Trial
NCT03087708
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
National Cancer Institute (NCI)
Condition
Stage IIIB Non-Small Cell Lung Cancer
Intervention
Naloxegol
Why stopped
Insufficient accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-17